Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
Platelets and vascular inflammation of the brain.
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Clinical characteristics of intermediate uveitis in adult Turkish patients.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Neuroinflammation: The Devil is in the Details.
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
Measurement characteristics and clinical utility of the 29-item Multiple Sclerosis Impact Scale.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
Assessment of upper limb motor function in patients with multiple sclerosis using the Virtual Peg Insertion Test: A pilot study.
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis.
Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains.
Pages
« first
‹ previous
…
511
512
513
514
515
516
517
518
519
…
next ›
last »